MDX Stock Overview
Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
MedX Health Corp Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.055 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.025 |
| Beta | 1.27 |
| 11 Month Change | -8.33% |
| 3 Month Change | 10.00% |
| 1 Year Change | -8.33% |
| 33 Year Change | -38.89% |
| 5 Year Change | -42.11% |
| Change since IPO | -81.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDX | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | 6.7% | 0.4% |
| 1Y | -8.3% | 3.7% | 21.4% |
Return vs Industry: MDX underperformed the Canadian Medical Equipment industry which returned 3.7% over the past year.
Return vs Market: MDX underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| MDX volatility | |
|---|---|
| MDX Average Weekly Movement | 21.4% |
| Medical Equipment Industry Average Movement | 13.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: MDX's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: MDX's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Stephen Lockyer | www.medxhealth.com |
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients’ mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
MedX Health Corp Fundamentals Summary
| MDX fundamental statistics | |
|---|---|
| Market cap | CA$14.86m |
| Earnings (TTM) | -CA$3.82m |
| Revenue (TTM) | CA$388.64k |
38.2x
P/S Ratio-3.9x
P/E RatioIs MDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDX income statement (TTM) | |
|---|---|
| Revenue | CA$388.64k |
| Cost of Revenue | CA$233.93k |
| Gross Profit | CA$154.71k |
| Other Expenses | CA$3.98m |
| Earnings | -CA$3.82m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 39.81% |
| Net Profit Margin | -983.43% |
| Debt/Equity Ratio | -78.6% |
How did MDX perform over the long term?
See historical performance and comparison